UPDATED May 22, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MBLY | US$27.81 | -3.8% | -31.1% | US$22.2b | US$38.41 | PS12.1x | E48.6% | n/a | ||
XPEV | US$8.75 | 9.5% | 1.2% | US$8.3b | US$12.86 | PS1.8x | E60.9% | n/a | ||
RIVN | US$10.70 | 4.9% | -25.6% | US$10.0b | US$15.53 | PS2.1x | E17.2% | n/a | ||
NIO | US$5.24 | -1.7% | -33.8% | US$10.9b | US$7.42 | PS1.4x | E43.9% | n/a | ||
QS | US$5.77 | -4.2% | -10.5% | US$2.8b | US$6.13 | PB2.3x | E-3.7% | n/a | ||
LCID | US$2.89 | -0.3% | -61.4% | US$6.6b | US$3.02 | PS10.8x | E23.4% | n/a |